Authors
Latest:
Emerging Treatments Over the Horizon for IBDJessica Allegretti, MD, MPH, and Edward Loftus Jr., MD, review emerging agents in the later phases for the management of IBD.
Latest:
Don't Miss a Beat: Putting Evidence-Based Cardiometabolic Therapies into Practice, with Taher Modarressi, MDTaher Modarressi, MD, sits down with hosts to share tips and practical nuggets for cardiometabolic health specialists to optimize prescription and adherence to newer therapies.
Latest:
Building Confidence in Biosimilars in OphthalmologyRishi P. Singh, MD; and Michael A. Klufas, MD, discuss how to gain both physician and patient trust when it comes to using biosimilars to treat ophthalmologic conditions.
Latest:
Rheumatoid Arthritis Quiz: TNF InhibitorsHow well do patients with rheumatoid arthritis adhere to treatment with a TNF inhibitor and how likely and long lasting is remission? Test your knowledge with this quiz.
Latest:
Looking Into the Future of Lipid ManagementDr Taub, Dr Patel, and Dr Kohli look ahead to the future of the management of cardiovascular risk and hyperlipidemia
Latest:
Clinical Pearls for the Management of ALGSExperts in pediatric hepatology share advice for the optimal management of Alagille syndrome.
Latest:
Case 3: 57-Year-Old Man With PsAAna-Maria Orbai, MD, MHS, leads the discussion on a real-world case scenario of a 57-year-old man who presents with severe plaque psoriasis and arthritis and shares clinical impressions as well as therapeutic goals for the patient.
Latest:
Focusing in on Novel Oral Systemic Therapies for Moderate Plaque Psoriasis: Medcast VideoLauren Miller, MPAS, PA-C, leads an expert discussion surrounding exciting developments in the treatment landscape of plaque psoriasis.
Latest:
Phase 2 Data Support Muvalaplin for Lowering Lp(a), with Stephen Nicholls, MBBS, PhDStephen Nicholls, MBBS, PhD, provides additional insight into KRAKEN trial data and the potential of muvalaplin.
Latest:
Esketamine Safety Mechanisms and BioavailabilityGeoffrey Grammer, MD closes this series highlighting the administration options of esketamine, its safety profile, and the importance of monitoring patients using this treatment.
Latest:
HIV: Treating Patients with Viral MutationsSorana Segal-Maurer, MD, offers clinical insights on treating patients with HIV who have viral mutations, including M184V, highlighting guideline recommendations.
Latest:
Key Takeaways and Prospective Treatment AdvancesDavid Hudesman, MD, Maia Kayal, MD, Miguel Regueiro, MD, Anita Afzali, MD, and Millie Long summarize their discussion of Inflammatory Bowel Disease (IBD) and discuss prospective advances in treatment options.
Latest:
The Multiple, Complex Challenges of Living with and Managing Liver DiseaseThis article is the final installment of four articles exploring the epidemic of liver disease called nonalcoholic fatty liver disease and its more severe form, nonalcoholic steatohepatitis.
Latest:
Pearls for Atopic Dermatitis ManagementExperts in dermatology share practice pearls and takeaways for treatment of atopic dermatitis.
Latest:
Novel Agents for the Management of Pediatric and Adult ADHDDrs Rakesh Jain, Greg Mattingly, David W. Goodman, Birgit H. Amann, and Theresa R. Cerulli, discuss emerging agents in the pipeline for the management of pediatric and adult ADHD.
Latest:
Helping Schools Calculate Respiratory Infection RiskWilson details how her team plans to develop risk assessment models to estimate respiratory viral infection risk reductions for interventions in elementary schools.
Latest:
Glucagon’s Role in Esophageal Foreign Body ImpactionFindings from a recent randomized controlled trial suggest glucagon does not improve EFBI resolution, time of endoscopy, or extraction length.
Latest:
Patient Education of HCMExpert cardiologists share strategies for educating patients on the treatment and management of hypertrophic cardiomyopathy.
Latest:
Unmet Needs in the Treatment of PBCExperts in hepatology review the unmet needs in primary biliary cholangitis, commenting on liver transplant, ethnic disparities, management of pruritis, as well as other symptoms.
Latest:
Biomarkers for IgANPanelists discuss potential biomarkers and clinical indicators that can aid in predicting disease outcomes for individual patients with IgA nephropathy.
Latest:
Anti-VEGF for RVO: The Gold StandardJohn W Kitchens, MD, bookends the discussion by highlighting the landscape of branch vein occlusion (BRVO) treatment options.
Latest:
Unmet Needs in the Treatment of PBCExperts in hepatology review the unmet needs in primary biliary cholangitis, commenting on liver transplant, ethnic disparities, management of pruritis, as well as other symptoms.
Latest:
Insulin Therapy and the Future of Type 2 Diabetes CareExpert clinicians discuss insulin therapy for treating type 2 diabetes and comment on what to look forward to in the future of diabetes care.
Latest:
Anti-VEGF for RVO: The Gold StandardJohn W Kitchens, MD, bookends the discussion by highlighting the landscape of branch vein occlusion (BRVO) treatment options.
Latest:
Practical Advice for Managing SARDs in the Current Treatment LandscapeClosing out their discussion, experts highlight practical advice for caring for patients with SARDs in the current treatment landscape.
Latest:
Clinical Pearls for RA ManagementNehad Soloman, MD; Joy Schechtman, DO; and Robert Levin, MD, share final thoughts and takeaways on the treatment of rheumatoid arthritis in the community setting.
Latest:
Collaboration and Communication Across the Healthcare TeamThe expert panel concludes its discussion with insights on how collaboration and communication across various healthcare specialties improve the care of patients treated for iron deficiency anemia.
